The Medicines and Healthcare Products Regulatory Agency (MHRA), the British body which imposed the ban, refused to give more details, claiming commercial confidentiality. Howard Pien, president and chief executive officer of Chiron Corporation, said the firm "deeply regrets that we will be unable to meet public health needs this season".